H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Go back to H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
(NASDAQ: NMRA) Delayed: 1.70 +0.08 (4.94%)
Previous Close $1.62    52 Week High
Open $1.62    52 Week Low
Day High $1.70    P/E N/A 
Day Low $1.61    EPS
Volume 517,501